← Companies|Emerald Health
Em

Emerald Health

Victoria CAFounded 201440 employees
Private CapbiotechPrivateCNS
Platform: Endocannabinoid
Market Cap
N/A
All Drugs
2
Clinical Trials
5
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
EME-9677EME-9677Phase 12ERTSMN2CGRPantHCCWM
EME-6317EME-6317Approved3RadioligandSOS1GLP-1/GIPMGCrohn's
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)
2028-12-28
EME-6317 Ph3 Readout
Crohn's
Ph3 Readout
2029-10-22
EME-9677 Interim
WM
Interim
2029-11-19
EME-9677 Interim
WM
Interim